Vitonnix: Building the Next Frontier of Nutritional Delivery through Oral Spray Innovation

Dr Prashant Jindal, Founder

Dr Prashant Jindal

Founder

The global nutraceutical industry is undergoing a pro­found transformation. As consumers become increas­ingly health-conscious and preventive healthcare gains prominence, attention is shifting beyond nutritional ingredi­ents to a more fundamental question: how effectively are those nutrients being absorbed and utilised by the body? While tra­ditional tablets, capsules, and gummies continue to dominate the market, growing awareness around bioavailability, con­venience, and consumer adherence is creating demand for al­ternative delivery formats that can improve real-world health outcomes.

Contributing to this shift is Vitonnix, a doctor-led nutritional wellness company focused on sublingual oral spray technology. Founded by UK-based ophthalmic surgeon Dr. Prashant Jindal, and Dr Deepti Jindal (Dermatologist), the company emerged from a clinical observation rather than a commercial trend.

What began as an investigation into persistent vitamin deficiencies despite regular supplementation has evolved into a broader platform addressing wellness, immunity, sleep, beauty, eye health, and preventive nutrition. In doing so, Vitonnix is helping shape an emerging conversation around delivery science and the future of nutritional healthcare.

Developed in the UK, the platform was subsequently introduced into India with the support and encouragement of the late Ratan Tata. Since then, Vitonnix has expanded into multiple health categories, has reached consumers across India, developing products across immunity, eye health, sleep, beauty and preventive nutrition, while continuing to invest in clinical validation across key formulations, including extensive clinical studies.

From Clinical Insight to Category Creation

Vitonnix's origins reflect an increasingly important trend within healthcare innovation: solutions born from practical clinical challenges rather than market speculation. Dr. Prashant Jindal's professional journey spans medical education in India, specialist ophthalmology training, and over two decades of clinical practice in the United Kingdom.

During this period, he encountered a recurring contradiction. Despite the widespread availability of nutritional supplements, deficiencies in essential vitamins and micronutrients continued to affect large sections of the population.

The experience prompted a deeper investigation into nutrient absorption and delivery mechanisms. Rather than focusing solely on ingredients, Dr. Jindal became increasingly interested in understanding why supplementation often failed to deliver expected outcomes. This exploration led to the development of an eye-health-focused nutritional product inspired by years of treating patients with retinal and vision-related conditions.

Over time, that initial concept evolved into a broader oral spray nutrition platform. Today, the company operates across multiple wellness categories while maintaining a consistent emphasis on accessibility, compliance, and effective nutrient delivery. The transition from a single clinical idea to a diversified health platform illustrates how physician-led innovation can identify opportunities that conventional consumer research may overlook.

Our focus is to combine clinical science with advanced delivery technologies that improve nutrient absorption, supported by collaborations with globally renowned medical professionals, scientists, and formulation experts

Dr Prashant Jindal, Founder

Rethinking Nutritional Delivery for Modern Consumers

One of the defining features of the nutraceutical sector is the growing recognition that consumer behaviour plays a significant role in health outcomes. The effectiveness of any supplement ultimately depends on whether individuals take it consistently and correctly.

Vitonnix has positioned itself around this challenge by focusing on sublingual spray technology. Unlike traditional formats that rely heavily on digestion and often require consumers to maintain structured routines, oral sprays are designed to integrate more seamlessly into daily life. Their portability, convenience, and ease of use address practical barriers that frequently undermine long-term adherence.

This approach reflects a broader shift occurring across healthcare and wellness industries, where user experience is becoming an increasingly important component of product design. The company views compliance not as a secondary consideration but as a critical determinant of effectiveness.

By simplifying the process of supplementation, Vitonnix aims to encourage consistent usage among consumers ranging from busy professionals and travelers to elderly individuals and younger users who may struggle with conventional tablets.

“In an increasingly crowded wellness market, this focus on behavioral adoption provides a distinctive strategic position, particularly as consumers seek solutions that fit naturally into their lifestyles”, adds Dr Prashant Jindal, Founder.

Building Credibility Through Science, Quality and Partnerships

As nutraceutical markets become more competitive, trust has emerged as one of the industry's most valuable assets. Product efficacy, manufacturing standards, and regulatory compliance increasingly influence consumer and stakeholder confidence.

Vitonnix has invested heavily in developing formulations through collaboration with medical professionals, scientists, and formulation specialists. According to the company, product development extends beyond ingredient selection to include considerations such as dosage accuracy, stability, taste optimisation, compatibility, and sublingual mucosal delivery.

This commitment to quality has also informed the company's broader growth strategy. Strategic partnerships have played a central role in expanding market access while reinforcing credibility. Support received during the company's early growth phase from the late Ratan Tata provided validation for the concept and helped accelerate its entry into the Indian market.

Similarly, the company's presence within established UK retail channels, including an upcoming launch with Boots UK after successfully completing its quality and regulatory assessment, has strengthened its international credentials and demonstrated its ability to meet rigorous quality expectations.

Rather than pursuing rapid expansion alone, the company has focused on building a foundation based on trust, scientific integrity, and long-term consumer confidence.

Scaling an Emerging Category

As preventive healthcare continues to gain momentum worldwide, the nutraceutical industry is entering a phase where delivery systems may become as important as nutritional formulations themselves. Consumers are increasingly seeking solutions that combine scientific credibility with convenience, consistency, and real-world effectiveness.

Vitonnix has positioned itself at the intersection of these evolving expectations. By approaching supplementation through the lens of absorption, adherence, and user experience, the company is contributing to a broader shift in how nutritional wellness products are designed and consumed.

As the market continues to mature, its focus on oral spray technology, scientific development, and category education places it among the businesses helping redefine the future of nutritional delivery.

For Vitonnix, the opportunity extends beyond building a successful brand; it lies in advancing a new approach to everyday nutrition that aligns more closely with the realities of modern healthcare and consumer behaviour.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

© 2026 India Pharma Outlook. All Rights Reserved.